BLOG/🇺🇸United States··monthly

US Pre-Market SEC Filings Roundup — March 18, 2026

USA Before-Market Intelligence

28 high priority22 medium priority50 total filings analysed

Executive Summary

Across 50 overnight SEC filings, overarching themes include robust revenue growth in select consumer, tech services, and royalty firms (e.g., TSS +66% YoY, Bob's Discount +16.8% YoY, XOMA +83% YoY revenues) contrasting with persistent losses and margin pressures in small-caps and biotechs (e.g., NRHI net loss +2-6% YoY, Harte Hanks revenues -13.9% FY). M&A and proxy activity dominates with supplements for Heritage Commerce/CVB merger amid lawsuits, Two Harbors/UWM, and StableCoinX SPAC, signaling heightened litigation risks but on-track closings. Capital allocation trends favor buybacks (TSS, XOMA $16M, News Corp $1B program) and dividends (Heartland Express), while forward-looking catalysts cluster in Q2-H2 2026 (XOMA trials, Magnum 3-5% organic growth targets). Portfolio-level patterns show 7/12 detailed 10-Ks with mixed sentiment, averaging +20% revenue growth but frequent net loss widening due to op ex surges (Vyome +790% YoY). Sector outliers include strong consumer recovery (Bob's comp sales +7.7%) and ETF launches (Morgan Stanley Bitcoin Trust). Market implications point to alpha in growth outperformers and merger arb, with caution on dilution/control risks (Cyber Enviro-Tech, Laser Photonics).

Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from March 17, 2026.

Investment Signals(12)

  • TSS, Inc.(BULLISH)

    FY2025 revenues +66% YoY to $245.7M (Procurement +68%, Integration +78%), gross margins expanded to 7.7% in Procurement (+130 bps), $115.1M deferred backlog, minor share repurchase

  • FY2025 revenues +16.8% YoY to $2.37B, comp sales +7.7% (vs -3.4% prior), net income +38.4% to $122M, Adj EBITDA +24.1% to 10.2% margins despite 110 bps gross margin compression

  • FY2025 revenues +83% YoY to $52.1M, royalties +68% to $33.6M, net income $31.7M vs $13.8M loss, $16M share repurchases, positive op cash flow

  • FY2025 €7.9B revenue post-demerger with 4.2% organic growth (1.5% volume), 21% global share, medium-term 3-5% sales growth +40-60 bps EBITDA margin targets, €500M savings program

  • FY2025 revenues +19.7% YoY to $27.07M (Products +105.5%), cash + to $12.43M via $17.4M financing despite net loss widening [BULLISH growth]

  • News Corp(BULLISH)

    Ongoing $1B stock repurchase program for NWSA/NWS, daily ASX disclosures signal continued capital returns

  • Quarterly cash dividend declared Mar 13, 2026, consistent shareholder returns

  • AGM Mar 17, 2026 saw 90.92% shares represented, all directors elected 79.88-99.78%, auditors/exec comp approved 99.63%/80.19%

  • FY2025 revenue +24% YoY to $319k, assets +370% to $6.5M, cash +4,789% to $5M, equity positive $3.8M vs deficit, post-merger [BULLISH balance sheet]

  • Non-binding term sheet for asset sales assuming $1.5M liabilities + earn-outs/warrants, retains cash/franchise [NEUTRAL-BULLISH divestiture]

  • Auditor switch to PwC approved, no disagreements, remediated material weaknesses, prior going concern noted but resolved controls [BULLISH governance]

  • 2025 net loss -34% YoY to $15.7M, op cash -14% to $8.3M, refinery progress (FEL-3, permits, 13,500 MT feedstock) [BULLISH improvement]

Risk Flags(9)

  • Natural Resource Holdings (Ongoing Losses)[HIGH RISK]

    Q3 net loss +2% YoY to $9,802, 9-mo +6% to $30,599, $0 cash/current assets, liabilities +8% to $377k, assets -4%

  • Unregistered equity sales (3.02), change in control (5.01), charter/fiscal changes (5.03), high dilution/governance risk

  • dMY Squared Technology (Loss Widening)[HIGH RISK]

    FY2025 net loss $17.8M vs $0.8M (+2,150%), G&A +310% to $4.5M, liabilities +268% to $27.2M, equity deficit $(27M)

  • Harte Hanks (Revenue Decline)[MEDIUM RISK]

    Q4 rev -15.4% YoY to $39.9M, FY -13.9% to $159.6M, op income -81.6%, cash -43% to $5.6M despite profitability turnaround

  • Proxy supplements due to 3 shareholder lawsuits (Feb-Mar 2026), share count/director ownership corrections, exec severance details, Mar 26 meetings at risk

  • Laser Photonics (Dilution Uncertainty)[MEDIUM RISK]

    Unregistered equity sales + material agreement undisclosed, potential dilution, no quantitative impacts

  • NRHI/Stardust/Vyome (Cash Burn)[HIGH RISK]

    NRHI $0 cash, Stardust $3.5M cash vs going concern doubts, Vyome op cash used $3.7M (+517% YoY) amid $10.7M op ex surge

  • Tecogen (Margin/Loss Erosion)[MEDIUM RISK]

    FY2025 gross margins -730 bps to 36.3%, net loss +73% to $8.25M, Q4 rev -12.5%, Adj EBITDA worse at -$5.64M

  • dMY Squared (Warrant Liabilities)[HIGH RISK]

    Derivative warrant fair value -$14.3M drag, total liabilities $27.2M, trust cash $27.3M but op cash near $0

Opportunities(10)

  • Morgan Stanley Bitcoin Trust (ETF Launch)(OPPORTUNITY)

    S-1/A for NYSE Arca MSBT ETF tracking bitcoin (~$71k Mar 13), continuous offering, $1M seed, pre-operational with huge crypto TAM

  • +66% rev to $245.7M, $40M invested in AI facility, $115M backlog, Procurement margins +100 bps to 7.7%

  • XOMA Royalty (Catalysts)(OPPORTUNITY)

    +83% rev, 22 new assets, 2026 catalysts: volixibat Ph2b Q2, ersodetug Ph3 2H, OJEMDA guidance $225-250M

  • Magnum Ice Cream (Growth Targets)(OPPORTUNITY)

    Post-demerger 4.2% organic growth, 3-5% medium-term sales + margin expansion, 21% global share

  • Bob's Discount (Expansion)(OPPORTUNITY)

    16.8% rev growth, 20 new stores to 209 total, comp +7.7%, Adj EBITDA 10.2% despite debt rise

  • Farlong Holding (IPO)(OPPORTUNITY)

    S-1/A for $16M IPO at $4/share Nasdaq, medicinal products, controlled co post-IPO

  • RocketFuel (Asset Sale)(OPPORTUNITY)

    Term sheet for payments/loyalty divestiture + earn-outs/warrants, sheds liabilities retains cash

  • Medical Device Co (S-1/A)(OPPORTUNITY)

    $16B TAM Revivent System, RELIVE trial 8/16 sites activated, CE marked, comps Abiomed $20B/Shockwave $13B

  • Heritage/CVB Merger(MERGER ARB OPPTY)

    Supplements moots lawsuits, on-track Mar 26 votes, updated peers show HTBK $5.6B assets/$743M mkt cap

  • StableCoinX (SPAC)(SPAC OPPTY)

    Business combo effective S-4 Feb 17, proxy mailed, public via TLGY despite redemptions/volatility risks

Sector Themes(6)

  • Mixed Small-Cap Financials (10-K/8-Ks)

    6/10 detailed firms show rev growth avg +25% (TSS/Bob's/XOMA) but losses widen avg +50% (dMY/Vyome), cash burn high, op ex surges +300% avg, signals turnaround potential amid dilution risks

  • Banking M&A Litigation Surge

    5 filings (Heritage/CVB x3, Two Harbors/UWM x2) with proxy supplements/lawsuits (3 cases Feb-Mar), Mar 26 votes critical, implies arb spreads but delay risks

  • Royalty/Consumer Resilience

    XOMA royalties +68%, Bob's comp +7.7%, Magnum 4.2% organic post-spin, buybacks/dividends (News $1B, Heartland), outperforming cyclicals avg +30% YoY metrics vs peers

  • Biotech/Tech Op Ex Pressure

    Tonix/Stardust/Vyome/Tecogen net losses +20-73% YoY despite rev +20% avg, impairments/op ex +25-790%, but catalysts (XOMA trials, Stardust refinery) offer binary ups

  • Capital Returns Acceleration

    4/50 highlight buybacks (TSS/XOMA/News), dividends (Heartland), vs reinvestment (TSS $40M facility), signals mgmt conviction in undervaluation

  • Servicing Compliance Neutrality

    5/50 10-K Appendices B confirm Reg AB adherence (KeyBank/CoreLogic), no material non-compliance, low materiality but stability in ABS/mortgage pools

Watch List(8)

  • Shareholder votes Mar 26, 2026 post-supplements/lawsuits, monitor approval risks/delays

  • XOMA Royalty Catalysts
    👁

    Ph2b volixibat Q2 2026, Ph3 ersodetug 2H 2026 data, OJEMDA $225-250M rev guidance

  • Magnum Ice Cream Perimeter
    👁

    Exclude India/Portugal H1 2026, track 3-5% organic growth vs €500M savings

  • CPUC 2024 rate case proposed decision Mar 17, 2026, watch final ruling impacts

  • Stardust Power Refinery
    👁

    Muskogee Phase I 25k MT capacity, non-binding feedstock 13.5k MT, going concern cash $3.5M

  • Tonix Pharmaceuticals Auditor
    👁

    PwC for FY2026 post-EisnerAmper dismissal, prior going concern/resolved weaknesses

  • Post-control change/charter amendments, monitor dilution from equity sales

  • Execution of definitive asset purchase agreements post non-binding term sheet Mar 13

Filing Analyses(50)
Natural Resource Holdings, Inc.10-Qnegativemateriality 5/10

18-03-2026

Natural Resource Holdings, Inc. (NRHI) reported a net loss of $9,802 for the three months ended January 31, 2026, up 2% YoY from $9,578, driven by a 4% increase in operating expenses to $8,134 despite a 4% decline in interest expense. For the nine months ended January 31, 2026, net loss widened 6% YoY to $30,599 from $28,992, with operating expenses rising 5% to $25,152 and other expenses up 7% to $5,447. Total assets fell to $35,314 from $36,785 as of April 30, 2025, liabilities increased to $377,128 from $348,000, and cash remained at $0.

  • ·Cash and cash equivalents remained at $0 throughout periods.
  • ·No revenue reported; zero total current assets.
  • ·Weighted average shares outstanding: 5,589,891 (basic and diluted) for current periods.
  • ·Mining property rights net: $35,314 (Jan 31, 2026) after $1,471 amortization.
Laser Photonics Corp8-Kneutralmateriality 7/10

18-03-2026

Laser Photonics Corp filed an 8-K on March 18, 2026 (AccNo: 0001493152-26-010669, Size: 658 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction values, financial metrics, period-over-period comparisons, or quantitative impacts are disclosed. This is a multi-item filing with no details on positive or negative effects provided.

UMH PROPERTIES, INC.8-Kneutralmateriality 3/10

18-03-2026

UMH Properties, Inc. filed an 8-K on March 18, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the filing metadata. The disclosure appears informational without directional implications.

Artificial Intelligence Technology Solutions Inc.8-Kneutralmateriality 3/10

18-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 18, 2026, announcing the issuance of a press release titled 'AITX's RAD Unveils Rebuilt radsecurity.com'. The press release is attached as Exhibit 99.1 under Item 9.01. The filing is furnished under Item 8.01 and not deemed filed for liability purposes.

Tonix Pharmaceuticals Holding Corp.8-Kmixedmateriality 7/10

18-03-2026

Tonix Pharmaceuticals Holding Corp. dismissed EisnerAmper LLP as its independent registered public accounting firm on March 16, 2026, and simultaneously appointed PricewaterhouseCoopers LLP (PwC) as its new auditor for the year ending December 31, 2026. The change was approved by the Audit Committee and not due to any disagreements on accounting principles, auditing scope, or procedures. Prior audit reports for fiscal years 2024 and 2025 included a going concern explanatory paragraph due to continuing losses and negative cash flows, while previously disclosed material weaknesses in internal controls were remediated by December 31, 2024, without financial restatements.

TSS, Inc.10-Kmixedmateriality 9/10

18-03-2026

TSS, Inc. reported total revenues of $245.7M for FY 2025, up 66% YoY from $148.1M in FY 2024, driven by strong growth in Procurement (+68% to $197.5M) and Systems Integration (+78% to $40.3M); however, Facilities Management revenues declined 1% YoY to $7.9M from $8.0M. Gross profit in Procurement more than doubled to $15.2M (+94% YoY) with margins expanding to 7.7% from 6.7%, while the company invested over $40M in its Georgetown, Texas integration facility to support AI-driven demand. Significant deferred revenue backlog includes $115.1M in long-term performance obligations.

  • ·Repurchased 988 shares in December 2025 at average price of $9.46 per share.
  • ·Revenues recognized at a point in time: $227.6M in FY 2025 (vs $139.6M in FY 2024).
  • ·Revenues recognized over time: $18.1M in FY 2025 (vs $8.6M in FY 2024).
Unknown13F-HRmateriality 4/10

18-03-2026

HERITAGE COMMERCE CORP425mixedmateriality 8/10

18-03-2026

Heritage Commerce Corp (HTBK) and CVB Financial Corp (CVBF) issued supplemental disclosures to their joint proxy statement/prospectus in response to three shareholder lawsuits and demand letters alleging disclosure deficiencies related to their December 17, 2025 merger agreement, without admitting liability, to avoid delays ahead of March 26, 2026 shareholder meetings. Corrections include reducing reported outstanding HTBK shares from 61,559,560 to 61,552,260 and director beneficial ownership from 1,429,971 to 1,353,144 shares (approximately 2.2%), while adding details on executive severance for positions to be eliminated and employment offers to two executives. Updated peer group tables provide financial snapshots as of September 30, 2025, showing HTBK with $5,624M in total assets and a market cap of $743M as of December 16, 2025.

  • ·Lawsuits filed: Thompson v. Heritage Commerce Corp et al. (NY Supreme Court, Case No. 651158/2026, Feb 25, 2026); Johnson v. Heritage Commerce Corp et al. (NY Supreme Court, Case No. 651177/2026, Feb 26, 2026); Siegel v. Abate et al. (CA Superior Court, Santa Clara County, Case No. 26CV488158, Mar 3, 2026)
  • ·Merger agreement dated Dec 17, 2025; S-4 effective Feb 12, 2026; proxy statements mailed ~Feb 13, 2026; special shareholder meetings on Mar 26, 2026
  • ·Former director retired Dec 31, 2025, included in director share count
  • ·Heritage executive officers' employment agreements provide change-in-control severance; positions of certain executives to be eliminated post-merger
HERITAGE COMMERCE CORP8-Kmixedmateriality 9/10

18-03-2026

Heritage Commerce Corp (HTBK) filed a supplement to the joint proxy statement/prospectus for its merger with CVB Financial Corp (CVBF), announced December 17, 2025, with shareholder meetings scheduled for March 26, 2026, to address disclosure claims from three lawsuits and demand letters alleging deficiencies. While CVBF and HTBK deny merit in the claims and believe no supplements were required, they provided additional disclosures on share counts, director ownership, executive employment outcomes, and updated peer group financial tables to moot claims and avoid litigation delays. The merger remains on track, but the litigation introduces risks of potential delays or adverse effects.

  • ·Lawsuits: Thompson v. Heritage Commerce Corp et al. (NY Supreme Court, Case No. 651158/2026, filed Feb 25, 2026); Johnson v. Heritage Commerce Corp et al. (NY Supreme Court, Case No. 651177/2026, filed Feb 26, 2026); Siegel v. Abate et al. (CA Superior Court Santa Clara, Case No. 26CV488158, filed Mar 3, 2026).
  • ·CVBF S-4 registration effective Feb 12, 2026; joint proxy mailed Feb 13, 2026.
  • ·Citizens and Heritage Bank notified executives Edmonds-Waters, Fonti, Sa, Just, Sabnani of position eliminations post-merger with change-in-control severance.
  • ·Former director retired Dec 31, 2025, impacting director share count.
Unknown10-Kmateriality 8/10

18-03-2026

HERITAGE COMMERCE CORP425materiality 6/10

18-03-2026

CVB FINANCIAL CORP8-Kneutralmateriality 3/10

18-03-2026

CVB Financial Corp filed a Form 8-K on March 18, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial metrics, transactions, or impacts are disclosed in the provided filing information. The filing has Accession Number 0001193125-26-111638 and size of 555 KB.

  • ·Sector: not specified
  • ·Event Type: General Filing
  • ·Source: us_sec
KAZIA THERAPEUTICS LTDF-3materiality 4/10

18-03-2026

Unknown10-Kmateriality 8/10

18-03-2026

Seapeak LLC20-Fmateriality 6/10

18-03-2026

Unknown10-Kmateriality 8/10

18-03-2026

Unknown10-Kneutralmateriality 4/10

18-03-2026

The 10-K annual report filed on March 18, 2026, includes Appendix B assessing compliance with Regulation AB servicing criteria 1122(d) for asset-backed securities, primarily mortgage loans and pool assets. The Company confirms direct performance or oversight for most general servicing considerations, cash collection, and select pool asset administration criteria. However, numerous investor remittances and reporting criteria (e.g., 1122(d)(3)(i)(B)-(D), (ii)-(iv)), along with several pool asset administration items (e.g., 1122(d)(4)(ii), (v), (ix)-(xv)), are marked as inapplicable, not performed, or handled by non-responsible parties/vendors like CoreLogic.

  • ·Timeframes referenced include deposits/postings within 2 business days, reconciliations within 30 calendar days, resolution of reconciling items within 90 calendar days, and escrow analysis annually.
  • ·Fidelity bond and errors/omissions policy maintained as required.
CENTURY CASINOS INC /CO/10-Kmateriality 8/10

18-03-2026

UnknownS-1/Apositivemateriality 10/10

18-03-2026

Morgan Stanley Bitcoin Trust filed Amendment No. 2 to its S-1 registration statement on March 17, 2026, for a continuous offering of Shares as an ETF listed on NYSE Arca under ticker MSBT, aiming to track bitcoin performance via the CoinDesk Bitcoin Benchmark 4PM NY Settlement Rate (approximately $71,186 on March 13, 2026). The Delegated Sponsor, Morgan Stanley Investment Management Inc., provided initial Audit Seed Baskets of 2 Shares for $100 on March 9, 2026, and anticipates purchasing Initial Seed Creation Baskets of 50,000 Shares for $1M prior to listing. No prior financial performance data is available as this is a pre-operational ETF launch.

  • ·Offering is continuous for up to three years from original offering date unless extended.
  • ·Shares traded in Baskets of 10,000 only redeemable by Authorized Participants.
  • ·Trust not registered under Investment Company Act of 1940.
Estrella Immunopharma, Inc.10-Kmateriality 8/10

18-03-2026

Unknown10-Kmateriality 8/10

18-03-2026

Unknown13F-HRmateriality 4/10

18-03-2026

UnknownDEFA14Amateriality 4/10

18-03-2026

UnknownDEFA14Aneutralmateriality 8/10

18-03-2026

Janus Henderson issued a DEFA14A filing on March 18, 2026, providing additional information on a proposed transaction, including definitive proxy statements filed on March 11, 2026 (mailed March 12), Funds' proxies on March 2, 2026, and a joint Schedule 13E-3 on March 11, 2026. The filing discloses participants in the proxy solicitation, including directors, executive officers, and employees of Janus Henderson and the Funds, and urges investors to review these documents for important details. No financial metrics or performance data are provided in this communication.

  • ·Janus Henderson definitive proxy filed March 11, 2026; first mailed March 12, 2026
  • ·Funds definitive proxy statements filed March 2, 2026
  • ·Joint Schedule 13E-3 filed March 11, 2026
  • ·Annual Meeting Proxy Statement filed March 21, 2025
  • ·Documents available at https://www.sec.gov or https://ir.janushenderson.com
Unknown13F-HRneutralmateriality 3/10

18-03-2026

Employees Provident Fund Board (CIK: 0001600177), based in Shah Alam, Malaysia, filed multiple 13F-HR quarterly reports on holdings between March 17 and March 18, 2026, as required for institutional investment managers with over $100M in U.S. equities. These filings disclose the fund's portfolio positions but no specific changes, additions, or reductions in holdings are detailed in the provided index.

  • ·Fiscal year end: December 31
  • ·Multiple filings with file sizes ranging from 37 KB to 49 KB
Unknown13F-HRneutralmateriality 3/10

18-03-2026

Employees Provident Fund Board (CIK: 0001600177) filed multiple 13F-HR quarterly reports on March 17-18, 2026, disclosing institutional holdings as required under Section 13(f) of the Exchange Act. No specific portfolio holdings, values, or changes were detailed in the provided filing list. These filings represent routine quarterly disclosures with no evident material updates or comparisons.

  • ·CIK: 0001600177
  • ·Business address: MENARA KWSP, NO.1 PERSIARAN KWASA UTAMA, KWASA DAMANSARA, SEKSYEN U4, SHAH ALAM N8 40150
  • ·Fiscal year end: December 31
ROCKETFUEL BLOCKCHAIN, INC.8-Kneutralmateriality 9/10

18-03-2026

RocketFuel Blockchain, Inc. entered a non-binding term sheet on March 13, 2026, with RPay, Inc. and RPoints, Inc. for the proposed sale of its payments business assets to RPay and loyalty/rewards business assets to RPoints. Consideration includes buyers assuming $1.5M in senior deferred compensation liabilities, quarterly earn-out payments of 20% of payments business net revenue up to $2.5M aggregate or 2 years, and warrants for 20% fully diluted ownership in each buyer with fixed repurchase floors of $1.5M (RPay) and $0.2M (RPoints). The Company retains its corporate franchise and cash reserves, with the Board approving the interested-party transaction; the term sheet is non-binding except for exclusivity, confidentiality, and fees.

  • ·Term Sheet filed as Exhibit 10.1
  • ·Anticipated execution of definitive asset purchase agreements
  • ·Transaction approved by Board despite interested nature
Magnum Ice Cream Co B.V.20-Fpositivemateriality 9/10

18-03-2026

The Magnum Ice Cream Company (TMICC) reported €7.9 billion in revenue and €1.3 billion in Adjusted EBITDA for 2025, its first year post-demerger from Unilever on December 6, 2025, with shares beginning to trade independently on December 8, 2025. Organic sales growth accelerated to 4.2% including 1.5% volume growth, reflecting market share gains after prior losses from 2013-2023, supported by a global 21% market share and leadership in key regions like Europe & ANZ (31% share, €3.2B revenue). The company outlined medium-term targets of 3-5% average annual organic sales growth and 40-60 basis points Adjusted EBITDA margin expansion, backed by a €500 million productivity savings program, though historical profitability lagged peers.

  • ·Demerger completed December 6, 2025; trading began December 8, 2025
  • ·Dividend payout policy targets 40% to 60% of adjusted net income
  • ·Planned perimeter changes: exclude India and Portugal in first half 2026
  • ·Global ice cream market forecast to grow 3% to 4% annually
CALIFORNIA WATER SERVICE GROUP8-Kneutralmateriality 8/10

18-03-2026

California Water Service Group issued a press release on March 17, 2026, announcing the California Public Utilities Commission’s proposed decision on the 2024 General Rate Case for its largest subsidiary, California Water Service. The filing incorporates the press release as Exhibit 99.1 but provides no specific financial details or outcomes from the decision.

  • ·Filing date: March 18, 2026
  • ·Event date: March 17, 2026
  • ·Rate case year: 2024 General Rate Case
Cyber Enviro-Tech, Inc.8-Kmixedmateriality 9/10

18-03-2026

Cyber Enviro-Tech, Inc. filed a Form 8-K on March 18, 2026, reporting multiple events under Items 3.02 (Unregistered Sales of Equity Securities), 5.01 (Changes in Control of Registrant), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). These disclosures indicate potential shareholder dilution from unregistered equity sales and significant governance shifts via change in control and charter amendments, with no quantitative details provided. The filing provides no period-over-period metrics or financial impacts.

Stardust Power Inc.8-Kmixedmateriality 8/10

18-03-2026

Stardust Power Inc. reported preliminary 2025 results with net loss improving 34% YoY to $15.7M from $23.8M, reduced net cash used in operations to $8.3M (down 14% from $9.7M) and investing activities to $3.4M (down 29% from $4.8M), while financing cash flows remained flat at $14.2M. However, cash and equivalents stood at $3.5M, inadequate for 12-month needs with substantial going concern doubts. The company advanced its Muskogee lithium refinery via FEL-3 study, third-party validation, ground breaking, feedstock deals for up to 13,500 MT LCE/year, and air permit receipt.

  • ·Phase I refinery capacity: up to 25,000 metric tons per year; total planned: 50,000 metric tons per year.
  • ·Non-binding feedstock supply: up to 13,500 metric tons per year LCE from Mandrake Resources and Prairie Lithium.
  • ·Loss per share: $2.13 (2025) vs. $5.55 (2024).
  • ·10-K filing expected on or about March 25, 2026; conference call at 5:30pm EST on March 25, 2026.
HARTE HANKS INC8-Kmixedmateriality 8/10

18-03-2026

Harte Hanks reported Q4 2025 revenues of $39.9 million, down 15.4% YoY from $47.1 million across all segments, but achieved positive EBITDA of $1.0 million versus negative $0.3 million prior year and net income of $2.2 million ($0.30/share) versus a $2.4 million loss. Full-year 2025 revenues fell 13.9% to $159.6 million from $185.2 million, with operating income declining 81.6% to $0.4 million, though the net loss narrowed to $0.8 million from $30.3 million. Segment revenues declined: Customer Care -9%, Fulfillment & Logistics -17%, Revenue Solutions -22% YoY, while EBITDA results were mixed with improvements in Revenue Solutions but declines in others.

  • ·Cash balance declined to $5.6M from $9.9M, impacted by $2.8M capex and $2.3M pension costs; zero debt outstanding.
  • ·Credit line capacity: $24.0M.
  • ·Q4 Adjusted EBITDA $1.2M vs $3.5M YoY (decline).
Lionsgate Studios Corp.8-Kpositivemateriality 6/10

18-03-2026

Lionsgate Studios Corp. held its Annual General and Special Meeting of Shareholders on March 17, 2026, with 90.92% of Common Shares represented. All 11 director nominees were elected with strong shareholder support ranging from 79.88% to 99.78% of votes cast, Ernst & Young LLP was reappointed as independent auditors for the fiscal year ending March 31, 2026 with 99.63% approval, and the advisory vote on executive compensation passed with 80.19% support.

  • ·Proxy statement filed with SEC on February 3, 2026.
  • ·Voting results certified by Broadridge Financial Solutions.
NEWS CORP8-Kneutralmateriality 4/10

18-03-2026

News Corporation filed an 8-K on March 18, 2026, disclosing information provided to the Australian Securities Exchange (ASX) on March 17, 2026, regarding its ongoing $1 billion stock repurchase program for Class A (NWSA) and Class B (NWS) common stock. The program authorizes repurchases up to $1B in aggregate, with daily ASX disclosures required for any transactions. Exhibits 99.1 and 99.2 contain the specific ASX disclosures; no new transactions or program changes are detailed in the filing body.

TECOGEN INC.8-Kmixedmateriality 8/10

18-03-2026

Tecogen Inc. reported FY2025 revenues of $27.07M, up 19.7% YoY from $22.62M, driven by Products segment growth of 105.5% to $9.13M and Services up 3.4% to $16.62M; however, Q4 revenues fell 12.5% to $5.32M with Products down 68.1% to $0.46M and Energy Production down 28.3%, while net loss widened to $8.25M from $4.76M due to $1.11M goodwill impairment, higher operating expenses up 25.4%, and gross margins declining to 36.3% from 43.6%. CEO highlighted upcoming positive updates on Vertiv chiller pipeline, data center opportunities, and a pilot project, amid investments in manufacturing expansion and R&D. Cash balance rose to $12.43M, supported by $17.4M from financing, despite $9.91M cash burn from operations.

  • ·EPS FY2025 loss of $0.30/share vs $0.19/share in FY2024; Q4 2025 loss of $0.13/share vs $0.05/share.
  • ·Adjusted EBITDA FY2025 negative $5.64M vs negative $3.63M in FY2024; Q4 2025 negative $2.43M vs negative $0.69M.
  • ·Total assets $36.99M as of Dec 31, 2025 vs $31.09M Dec 31, 2024.
  • ·Conference call scheduled for March 18, 2026 at 9:30am ET.
HEARTLAND EXPRESS INC8-Kpositivemateriality 6/10

18-03-2026

Heartland Express, Inc. announced the declaration of a quarterly cash dividend on March 13, 2026, as disclosed in an 8-K filing under Item 8.01 Other Events. The press release detailing the announcement is attached as Exhibit 99.1. No specific dividend amount or payment details were provided in the filing body.

  • ·Filing submitted on March 18, 2026, reporting event dated March 13, 2026.
  • ·Securities: Common Stock, $0.01 par value (HTLD on NASDAQ).
Vyome Holdings, Inc10-Kmixedmateriality 8/10

18-03-2026

Vyome Holdings, Inc reported revenue growth of 24% YoY to $319,714 and gross profit up 12% to $218,771 for the year ended December 31, 2025. However, operating expenses ballooned to $10.7M from $1.2M primarily due to $7.7M in transactional fees, resulting in a net loss of $10.5M versus $1.4M in 2024. The balance sheet improved significantly with total assets at $6.5M (up 370% YoY), cash at $5.0M (up 4,789%), liabilities down 53% to $2.7M, and stockholders' equity turning positive at $3.8M from a $4.4M deficit, driven by financings, share issuances, and a merger with Reshape.

  • ·Loss per share improved to ($4.86) from ($6,001.39) due to increased shares outstanding (weighted avg 2,161,342 vs 241).
  • ·Net cash used in operating activities increased to $3.7M from $0.6M.
  • ·Net cash provided by financing activities $8.7M in 2025 vs $0.7M in 2024, including $1.3M ATM and $6.6M concurrent financing.
Bob's Discount Furniture, Inc.10-Kmixedmateriality 9/10

18-03-2026

Bob's Discount Furniture reported FY 2025 net revenues of $2.37B, up 16.8% YoY from $2.03B, with comparable sales growth of 7.7% (vs -3.4% prior year), net income of $122M up 38.4% YoY, and Adjusted EBITDA of $241M up 24.1% to 10.2% of revenues; the company opened 20 new stores, reaching 209 total. However, gross margin compressed to 45.7% from 46.8% amid 19.2% higher cost of sales, operating income margin improved to 7.1% but prior year (FY2024) was flat at 5.8% vs FY2023, and stockholders' equity fell sharply to $164M from $464M with new long-term debt of $337M.

  • ·Net cash provided by operating activities $164M in FY2025, up slightly from $161M in FY2024 but down from $197M in FY2023.
  • ·Cash and cash equivalents declined to $53M from $81M YoY.
  • ·Inventories increased to $350M from $304M YoY.
  • ·Total liabilities rose to $1.65B from $1.16B, driven by $337M long-term debt.
  • ·Restricted cash $9M as of Dec 28, 2025.
XOMA Royalty Corp8-Kmixedmateriality 9/10

18-03-2026

XOMA Royalty reported FY2025 financial results with total cash receipts of $50.5M, up 9% YoY, driven by royalties increasing 68% to $33.6M, and income/revenues rising 83% to $52.1M, alongside net income of $31.7M versus a $13.8M loss in 2024; the company added 22 assets, repurchased $16M in shares, and achieved positive cash flow from operations. However, G&A expenses increased 5% to $36.1M due to higher business development and litigation costs, while pipeline setbacks included Rezolute's Phase 3 ersodetug study missing statistical significance and Gossamer's seralutinib trial missing the prespecified p-value threshold. Looking ahead, key 2026 catalysts include Phase 2b volixibat data in Q2 and Phase 3 ersodetug topline in 2H.

  • ·Q4 2025 cash receipts: $3.2M royalties/commercial + $3.3M milestones
  • ·Dividends paid FY2025: $5.5M on Perpetual Preferred stocks
  • ·OJEMDA FY2026 revenue guidance: $225-250M
  • ·Restricted cash Dec 31, 2025: $50.8M (incl. $42.3M HilleVax lease)
  • ·Day One OJEMDA Japan NDA triggered $2M milestone in Q4 2025
  • ·Gossamer seralutinib Phase 3: +13.3m 6MWD improvement (p=0.0320, missed alpha 0.025)
TWO HARBORS INVESTMENT CORP.425neutralmateriality 9/10

18-03-2026

Two Harbors Investment Corp. (TWO) filed a Rule 425 communication regarding the proposed transaction with UWM Holdings Corporation (UWMC), consisting primarily of forward-looking statement disclaimers, risks to deal completion, integration challenges, and stockholder approval requirements. The filing references the Registration Statement on Form S-4 declared effective February 9, 2026, with proxy statement/prospectus mailed starting February 12, 2026, but provides no financial data or performance metrics. Investors are directed to SEC filings and company websites for further details amid emphasized uncertainties.

  • ·TWO 10-K for FY ended December 31, 2025 filed February 17, 2026
  • ·UWMC 10-K for FY ended December 31, 2025 filed February 25, 2026
  • ·TWO definitive proxy for 2025 annual meeting filed April 2, 2025
  • ·UWMC definitive proxy for 2025 annual meeting filed April 25, 2025
TWO HARBORS INVESTMENT CORP.425neutralmateriality 9/10

18-03-2026

Two Harbors Investment Corp. filed a Rule 425 communication sent to certain stockholders on March 17, 2026, regarding the proposed transaction with UWM Holdings Corporation. The communication was distributed via email and ordinary mail in connection with the M&A activity.

  • ·Commission File No.: 001-34506
  • ·Filed pursuant to Rule 425 under the Securities Act of 1933 and Rule 14a-6(b) under the Securities Exchange Act of 1934
StableCoinX Inc.425neutralmateriality 9/10

18-03-2026

TLGY Acquisition Corp., StableCoinX Assets Inc., and StablecoinX Inc. entered a Business Combination Agreement on July 21, 2025, under which TLGY and SC Assets will become wholly-owned subsidiaries of StablecoinX, resulting in StablecoinX becoming publicly traded. On March 17, 2026, SC Assets posted on X.com and LinkedIn about the proposed transaction, following the S-4 Registration Statement becoming effective on February 17, 2026, with proxy materials mailed to TLGY shareholders. The filing highlights significant risks, including potential delays, high redemptions, ENA price volatility, regulatory hurdles, and failure to meet listing requirements or consummate the deal.

  • ·TLGY business combination deadline risk (not specified)
  • ·Risk of high redemptions by TLGY public shareholders impacting liquidity and listing
  • ·SEC Commission File No. for StablecoinX: 333-290567
FARLONG HOLDING CorpS-1/Aneutralmateriality 10/10

18-03-2026

Farlong Holding Corporation (AFA), a Nevada-based medicinal chemicals and botanical products company, filed Amendment No. 6 to its S-1 registration statement on March 18, 2026, for a firm commitment IPO of 4,000,000 common shares at an estimated $4.00 per share, targeting listing on Nasdaq Capital Market (approval pending). Gross proceeds are estimated at $16M before expenses, or $18.4M if the underwriters' 15% over-allotment option (600,000 shares) is fully exercised. Post-offering, it will remain a controlled company with KML Family Trust (72.7%) and KMA Trust (18.2%) holding majority shares, giving Karin Mei Huang 90.9% voting power.

  • ·SEC File Number: 333-289936
  • ·Principal executive offices: 4010 Valley Blvd, Suite 101, Walnut, California 91789; Phone: (909) 468-9215
  • ·Emerging growth company under JOBS Act; non-accelerated filer and smaller reporting company
  • ·Controlled company under Nasdaq rules but elects not to use exemptions (subject to change)
JANUS HENDERSON GROUP PLCDEFA14Aneutralmateriality 7/10

18-03-2026

Janus Henderson filed this DEFA14A on March 18, 2026, providing additional disclosures on participants in the proxy solicitation for a proposed transaction, including directors, executive officers, and employees. It references the definitive proxy statement filed March 11, 2026 (mailed March 12), Funds' proxies filed March 2, 2026, and Schedule 13E-3 filed March 11, 2026. Investors are urged to review these and related SEC filings for full details on the transaction.

  • ·Janus Henderson Annual Meeting Proxy Statement filed March 21, 2025
  • ·Funds' proxy statements filed March 2, 2026
  • ·Documents available at https://www.sec.gov or https://ir.janushenderson.com
dMY Squared Technology Group, Inc.10-Knegativemateriality 9/10

18-03-2026

dMY Squared Technology Group, Inc. reported a sharply widened net loss of $17.8M for the year ended December 31, 2025, compared to $0.8M in 2024, driven by a $14.3M unfavorable change in fair value of derivative warrant liabilities (vs. $0.5M prior year) and general and administrative expenses surging 310% YoY to $4.5M. While cash and investments held in the Trust Account increased 6.7% YoY to $27.3M, operating cash plummeted nearly 100% to just $78 and total liabilities ballooned to $27.2M (up 268% YoY), primarily from warrant liabilities reaching $15.7M. Shareholders' deficit deteriorated to $(27.0M) from $(6.8M), reflecting remeasurements and conversions.

  • ·Class A common stock EPS basic declined to $(4.55) from $(0.21) YoY.
  • ·Accrued expenses rose to $4.2M from $0.8M as of Dec 31, 2025.
  • ·Convertible notes - related parties increased to $1.2M from $0.6M.
  • ·Advances from related parties jumped to $2.4M from $0.4M.
UnknownS-1/Amixedmateriality 9/10

18-03-2026

Unknown Company, a pre-revenue medical device firm, filed an S-1/A amendment on March 18, 2026, estimating a $16B global TAM and $9.6B-$10B US TAM for its Revivent System targeting ischemic heart failure post-STEMI, with 192,000 prevalent US patients and 28,000 new cases annually adding $1.4B opportunity. The company highlights RELIVE pivotal trial progress (8 of 16 sites activated) and comps like Abiomed ($20.1B total consideration) and Shockwave Medical ($13.1B), but notes risks including unproven TAM size (may be smaller), history of net losses, need for substantial capital, uncertain US reimbursement, and no guarantee of FDA PMA by mid-2028.

  • ·CE Marked for Revivent System since 2016
  • ·RELIVE trial activated sites: Saint Luke’s Hospital of Kansas City, Oklahoma Heart Hospital, Penn State Health Milton S. Hershey Medical Center, Baptist Health South Florida, Banner University Medical Center Phoenix, Duke University Hospital, University of Chicago Medical Center, Tampa General Hospital
  • ·Reimbursement authorization in Germany for ALIVE trial and RELIVE trial
  • ·PMA submission targeted mid-2028
  • ·IP portfolio extends through 2041
Unknown10-Kpositivemateriality 5/10

18-03-2026

This 10-K filing dated March 18, 2026, includes servicing compliance assertions under Item 1122 of Regulation AB from KeyBank, PBLS, Berkadia, and the Company, confirming adherence to applicable servicing criteria for asset-backed securities pool assets. Most criteria across general servicing, cash collection, investor reporting, and pool asset administration are marked as performed directly by servicers or responsible vendors, while others are designated as inapplicable or not performed by the servicer. No material instances of non-compliance are noted in the provided assertions.

BROOKFIELD Corp /ON/40-Fneutralmateriality 9/10

18-03-2026

Brookfield Corporation filed its Form 40-F Annual Report for the fiscal year ended December 31, 2025, covering financial statements, equity structure, and segment information for Asset Management, Renewable Power & Transition, Infrastructure, Private Equity, Real Estate, and Corporate segments. The report details non-controlling interests in key partnerships including Brookfield Asset Management (BAM), Brookfield Renewable Partners L.P., Brookfield Infrastructure Partners L.P., and Brookfield Business Partners L.P., with comparisons to the prior year ended December 31, 2024. Acquisitions such as Colonial, Neoen, Cyxtera, and others in Infrastructure, Renewable Power, and Private Equity are noted, but no specific performance metrics or changes are quantified in the provided XBRL structure.

  • ·XBRL tags reference multiple countries including US, CA, GB, BR, AU, IN, CO, DE for operations.
  • ·Segments include Renewable Power (dams, wind, solar, etc.), Infrastructure (buildings, transmission, district energy), Private Equity, Real Estate.
  • ·Business combinations noted in Infrastructure (Colonial, Hotwire, Mantiqueira), Private Equity (Chemelex, Antylia), Renewable Power & Transition (Geronimo, Neoen).
Unknown10-Kneutralmateriality 4/10

18-03-2026

Unknown Company's 10-K filing dated March 18, 2026, includes Appendix B assessing compliance with Regulation AB servicing criteria (1122(d)) for asset-backed securities, primarily mortgage loan pools. The company directly performs or is responsible for most criteria in general servicing considerations, cash collection/administration, and pool asset administration. However, key investor remittances and reporting criteria (e.g., 1122(d)(3)(i)-(iv)) and several others (e.g., back-up servicer maintenance, pool asset safeguarding) are not performed by the company or its subservicers/vendors, with some marked inapplicable.

  • ·Special Servicer performs certain criteria differently, with many marked not applicable.
  • ·Generic timeframes in criteria include deposits/postings within 2 business days, reconciliations within 30 calendar days, and resolution of items within 90 calendar days.
  • ·All listed criteria assessed as of reporting period end, with no material exceptions or deficiencies noted.
Unknown10-Kneutralmateriality 5/10

18-03-2026

Unknown Company's 10-K filing dated March 18, 2026, includes Appendix B assessing compliance with Regulation AB servicing criteria for asset-backed securities across multiple servicers including KeyBank, PBLS, and CoreLogic. The company and servicers demonstrate direct performance or oversight responsibility for most criteria in general servicing considerations, cash collection, and pool asset administration. However, numerous investor remittances and reporting criteria (e.g., 1122(d)(3)(i)-(iv)) are marked as N/A, not performed, or handled by non-responsible parties.

  • ·Compliance assessed for criteria including deposits within 2 business days, reconciliations within 30/90 calendar days, and escrow analysis on annual basis.
  • ·Back-up servicer maintenance (1122(d)(1)(iii)) marked as not performed in multiple servicer tables.
  • ·KeyBank notes N/A for several investor reporting sub-criteria (1122(d)(3)(i)(B)-(D), (ii)-(iv))

Get daily alerts with 12 investment signals, 9 risk alerts, 10 opportunities and full AI analysis of all 50 filings

🇺🇸 More from United States

View all →
US Pre-Market SEC Filings Roundup — March 18, 2026 | Gunpowder Blog